Pharmacy Technician Pulse

Cybin bags breakthrough tag for psychedelic depression drug

pharmaphorum

MARCH 14, 2024

Cybin files a $150m placement on the back of new clinical data with its psychedelic drug CYB003 for depression and an FDA breakthrough designation.

FDA

PharmaShots Weekly Snapshots (June 05 – 09, 2023)

PharmaShots

JUNE 9, 2023

Quell Therapeutics Signed an Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies Date: June 09, 2023 | Tags: Quell Therapeutics, AstraZeneca, Engineered Treg Cell Therapies, Type 1 Diabetes, Inflammatory Bowel Disease, Biotech, Treg cell engineering modules Astellas and the (..)

FDA

PharmaShots Weekly Snapshots (January 23 - 27, 2023)

PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA

FDA Immunization

PharmaShots Weekly Snapshots (April 10 - 14, 2023)

PharmaShots

APRIL 14, 2023

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. However Nokia famously ran into trouble when it tried to develop VR products for digital health and its OZO camera failed to catch on, mainly because of a high $60,000 price tag.

Hospitals

Axsome bounces back as FDA clears depression drug

pharmaphorum

AUGUST 21, 2022

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The post Axsome bounces back as FDA clears depression drug appeared first on. Photo by Sydney Sims on Unsplash.

FDA

FDA Labelling

J&J builds case for antidepressant Spravato with head-to-head trial

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments.

Labelling

Labelling Hospitals

Blue Note leukaemia DTx gets FDA breakthrough tag

pharmaphorum

JANUARY 11, 2022

The DTx, called BNT200, is described as a first-of-its-kind DTx to treat anxiety and depression in adults with acute myeloid leukaemia (AML) who are hospitalised for a regimen of high-intensity induction chemotherapy. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on.

FDA

FDA Chemotherapy Hospitals

Hydrocodone acetaminophen alternatives: What can I take instead of hydrocodone acetaminophen?

The Checkup by Singlecare

MARCH 21, 2023

These alternative prescription medications include other types of opioids , NSAIDs like Advil or Motrin ( ibuprofen ) or Aleve ( naproxen ), and some medications used for depression or seizures, like Cymbalta (duloxetine) or gabapentin. mg to 2 mg every 4 hours as needed – adjust according to response IM, SubQ: 0.2

Dosage

Dosage Controlled Substances Labelling Packaging

Tramadol (Ultram) alternatives: What can I take instead of tramadol?

The Checkup by Singlecare

MAY 8, 2023

In addition to typical side effects seen with opioids, such as sedation and respiratory depression, the side effects of tramadol also include seizures and low blood sugar, among others. This is also beneficial as it allows for a wider safety margin; certain effects, like respiratory depression, also plateau despite increasing doses.

Controlled Substances

Controlled Substances Dosage Labelling FDA

High blood sugar symptoms: What are the early signs of high blood sugar?

The Checkup by Singlecare

JANUARY 19, 2023

There may also be skin tags in these areas. Diabetes People with diabetes have a fasting blood sugar of 126 mg/dl or more. People with insulin resistance or prediabetes may not have any symptoms. There may be darkened skin in the armpits or around the neck—this is called acanthosis nigricans.

Immunization

Immunization Hospitals Communication

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

The Physician Pharmacist

SEPTEMBER 14, 2023

It was depressing, it was just absolutely not something I could see myself doing. When I took it in pharmacy school, I thought that that was going to be a really a really high a really strong interest for me going into medicine. I in that I did a Clinical Oncology rotation at the Johns Hopkins Hospital in Baltimore, and hated it.

Medical Schools

Medical Schools Hospitals Communication Patient Care

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

JUNE 8, 2020

We are now in a 20-yearlong economic depression for the working and middle class as a result of health care prices inflating, prices not cost. Dave (HR): Yeah, I mean really everything we’re doing you know is about overturning the devastating effects of the status quo health plans. So that individuals can realize their full potential.

Health and Personal Care Stores

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies

Pharmacy Technician Pulse

Cybin bags breakthrough tag for psychedelic depression drug

PharmaShots Weekly Snapshots (June 05 – 09, 2023)

Trending Sources

PharmaShots Weekly Snapshots (January 23 - 27, 2023)

PharmaShots Weekly Snapshots (April 10 - 14, 2023)

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

Axsome bounces back as FDA clears depression drug

J&J builds case for antidepressant Spravato with head-to-head trial

Blue Note leukaemia DTx gets FDA breakthrough tag

Hydrocodone acetaminophen alternatives: What can I take instead of hydrocodone acetaminophen?

Tramadol (Ultram) alternatives: What can I take instead of tramadol?

High blood sugar symptoms: What are the early signs of high blood sugar?

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

Ep. 005 – Dave Chase Podcast Transcript

Stay Connected